My Quote Request
6505-01-144-1185
20 Products
NDC54569-4903-04
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011441185
NSN
6505-01-144-1185
NDC54569-4903-04
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011441185
NSN
6505-01-144-1185
MFG
ALLSCRIPTS HEALTHCARE SOLUTIONS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 750.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 750MG I.S. 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: FILM,NONENTERIC; EQUIVALENT TO 10 MEQ POTASSIUM CHLORIDE
Related Searches:
NDC00065-0630-06
NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE OPHTHALMIC SUSPENSION,USP
NSN, MFG P/N
6505011439509
NSN
6505-01-143-9509
NDC00065-0630-06
NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE OPHTHALMIC SUSPENSION,USP
NSN, MFG P/N
6505011439509
NSN
6505-01-143-9509
MFG
ALCON LABORATORIES INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS DEXAMETHASONE PER MILLILITER AND 3.500 MILLIGRAMS NEOMYCIN EQUIVALENT PER MILLILITER AND 10000.000 USP UNITS POLYMYXIN B EQUIVALENT PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NEOMYCIN AND POLYMYXIN B SULF AND DEXAMETH OPHTH SUSP USP 5ML
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH OPHTHALMIC TIP
Related Searches:
NDC00402-0771-05
NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE OPHTHALMIC SUSPENSION,USP
NSN, MFG P/N
6505011439509
NSN
6505-01-143-9509
NDC00402-0771-05
NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE OPHTHALMIC SUSPENSION,USP
NSN, MFG P/N
6505011439509
NSN
6505-01-143-9509
MFG
STERIS LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS DEXAMETHASONE PER MILLILITER AND 3.500 MILLIGRAMS NEOMYCIN EQUIVALENT PER MILLILITER AND 10000.000 USP UNITS POLYMYXIN B EQUIVALENT PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NEOMYCIN AND POLYMYXIN B SULF AND DEXAMETH OPHTH SUSP USP 5ML
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH OPHTHALMIC TIP
Related Searches:
NDC00998-0630-06
NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE OPHTHALMIC SUSPENSION,USP
NSN, MFG P/N
6505011439509
NSN
6505-01-143-9509
NDC00998-0630-06
NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE OPHTHALMIC SUSPENSION,USP
NSN, MFG P/N
6505011439509
NSN
6505-01-143-9509
MFG
ALCON LABORATORIES INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS DEXAMETHASONE PER MILLILITER AND 3.500 MILLIGRAMS NEOMYCIN EQUIVALENT PER MILLILITER AND 10000.000 USP UNITS POLYMYXIN B EQUIVALENT PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NEOMYCIN AND POLYMYXIN B SULF AND DEXAMETH OPHTH SUSP USP 5ML
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH OPHTHALMIC TIP
Related Searches:
NDC17478-0239-10
NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE OPHTHALMIC SUSPENSION,USP
NSN, MFG P/N
6505011439509
NSN
6505-01-143-9509
NDC17478-0239-10
NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE OPHTHALMIC SUSPENSION,USP
NSN, MFG P/N
6505011439509
NSN
6505-01-143-9509
MFG
AKORN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS DEXAMETHASONE PER MILLILITER AND 3.500 MILLIGRAMS NEOMYCIN EQUIVALENT PER MILLILITER AND 10000.000 USP UNITS POLYMYXIN B EQUIVALENT PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NEOMYCIN AND POLYMYXIN B SULF AND DEXAMETH OPHTH SUSP USP 5ML
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH OPHTHALMIC TIP
Related Searches:
NDC24208-0830-60
NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE OPHTHALMIC SUSPENSION,USP
NSN, MFG P/N
6505011439509
NSN
6505-01-143-9509
NDC24208-0830-60
NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE OPHTHALMIC SUSPENSION,USP
NSN, MFG P/N
6505011439509
NSN
6505-01-143-9509
MFG
PHARMAFAIR INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS DEXAMETHASONE PER MILLILITER AND 3.500 MILLIGRAMS NEOMYCIN EQUIVALENT PER MILLILITER AND 10000.000 USP UNITS POLYMYXIN B EQUIVALENT PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NEOMYCIN AND POLYMYXIN B SULF AND DEXAMETH OPHTH SUSP USP 5ML
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH OPHTHALMIC TIP
Related Searches:
NDC58768-0250-05
NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE OPHTHALMIC SUSPENSION,USP
NSN, MFG P/N
6505011439509
NSN
6505-01-143-9509
NDC58768-0250-05
NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE OPHTHALMIC SUSPENSION,USP
NSN, MFG P/N
6505011439509
NSN
6505-01-143-9509
MFG
IOLAB CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS DEXAMETHASONE PER MILLILITER AND 3.500 MILLIGRAMS NEOMYCIN EQUIVALENT PER MILLILITER AND 10000.000 USP UNITS POLYMYXIN B EQUIVALENT PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NEOMYCIN AND POLYMYXIN B SULF AND DEXAMETH OPHTH SUSP USP 5ML
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH OPHTHALMIC TIP
Related Searches:
NDC00182-6096-67
MULTIVITAMIN AND SODIUM FLUORIDE SOLUTION
NSN, MFG P/N
6505011439511
NSN
6505-01-143-9511
NDC00182-6096-67
MULTIVITAMIN AND SODIUM FLUORIDE SOLUTION
NSN, MFG P/N
6505011439511
NSN
6505-01-143-9511
MFG
IVAX CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1500.000 INTERNATIONAL UNITS VITAMIN A PER MILLILITER AND 400.000 INTERNATIONAL UNITS VITAMIN D PER MILLILITER AND 5.000 INTERNATIONAL UNITS VITAMIN E PER MILLILITER AND 0.400 MILLIGRAMS VITAMIN B6 PER MILLILITER AND 35.000 MILLIGRAMS VITAMIN C PER
ADMINISTRATION: ORAL
FLAVOR: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MULTIPLE VITAMIN AND SODIUM FLUORIDE SOLUTION 50 DOSES
PHARMACEUTICAL VEHICLE TYPE: ALCOHOLIC
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SUFFICIENT FOR 50 DOSES; SUITABLE FOR PEDIATRIC USE; SCREW-CAP DROPPER,CALIBRATED TO PROVIDE THE DAILY RECOMMENDED DOSE,SHALL BE ATTACHED TO BOTTLE OR SUPPLIED SEPARATELY IN PACKAGE
TOTAL PRIMARY CONTAINER QUANTITY: 1
~1: MILLILITER AND 0.250 MILLIGRAMS FLUORIDE PER MILLILITER AND 0.500 MILLIGRAMS THIAMINE PER MILLILITER AND 0.600 MILLIGRAMS RIBOFLAVIN PER MILLILITER AND 8.000 MILLIGRAMS NIACIN PER MILLILITER AND 0-2.000 MCG VITAMIN B12
Related Searches:
NDC00603-1449-47
MULTIVITAMIN AND SODIUM FLUORIDE SOLUTION
NSN, MFG P/N
6505011439511
NSN
6505-01-143-9511
NDC00603-1449-47
MULTIVITAMIN AND SODIUM FLUORIDE SOLUTION
NSN, MFG P/N
6505011439511
NSN
6505-01-143-9511
MFG
GENERICS BIDCO I LLC DBA QUALITEST PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1500.000 INTERNATIONAL UNITS VITAMIN A PER MILLILITER AND 400.000 INTERNATIONAL UNITS VITAMIN D PER MILLILITER AND 5.000 INTERNATIONAL UNITS VITAMIN E PER MILLILITER AND 0.400 MILLIGRAMS VITAMIN B6 PER MILLILITER AND 35.000 MILLIGRAMS VITAMIN C PER
ADMINISTRATION: ORAL
FLAVOR: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MULTIPLE VITAMIN AND SODIUM FLUORIDE SOLUTION 50 DOSES
PHARMACEUTICAL VEHICLE TYPE: ALCOHOLIC
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SUFFICIENT FOR 50 DOSES; SUITABLE FOR PEDIATRIC USE; SCREW-CAP DROPPER,CALIBRATED TO PROVIDE THE DAILY RECOMMENDED DOSE,SHALL BE ATTACHED TO BOTTLE OR SUPPLIED SEPARATELY IN PACKAGE
TOTAL PRIMARY CONTAINER QUANTITY: 1
~1: MILLILITER AND 0.250 MILLIGRAMS FLUORIDE PER MILLILITER AND 0.500 MILLIGRAMS THIAMINE PER MILLILITER AND 0.600 MILLIGRAMS RIBOFLAVIN PER MILLILITER AND 8.000 MILLIGRAMS NIACIN PER MILLILITER AND 0-2.000 MCG VITAMIN B12
Related Searches:
BREONESIN
GUAIFENESIN CAPSULES,USP
NSN, MFG P/N
6505011441179
NSN
6505-01-144-1179
MFG
GUTZ LOGISTICS INC
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 200.000 MILLIGRAMS OF QUAIFENESIN ACTIVE INGREDIENTS
Related Searches:
NDC00057-1050-10
GUAIFENESIN CAPSULES,USP
NSN, MFG P/N
6505011441179
NSN
6505-01-144-1179
NDC00057-1050-10
GUAIFENESIN CAPSULES,USP
NSN, MFG P/N
6505011441179
NSN
6505-01-144-1179
MFG
GUTZ LOGISTICS INC
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 200.000 MILLIGRAMS OF QUAIFENESIN ACTIVE INGREDIENTS
Related Searches:
K-TABS
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011441185
NSN
6505-01-144-1185
K-TABS
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011441185
NSN
6505-01-144-1185
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 750.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 750MG I.S. 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: FILM,NONENTERIC; EQUIVALENT TO 10 MEQ POTASSIUM CHLORIDE
Related Searches:
KLOTRIX
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011441185
NSN
6505-01-144-1185
KLOTRIX
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011441185
NSN
6505-01-144-1185
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 750.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 750MG I.S. 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: FILM,NONENTERIC; EQUIVALENT TO 10 MEQ POTASSIUM CHLORIDE
Related Searches:
NDC00074-7804-11
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011441185
NSN
6505-01-144-1185
NDC00074-7804-11
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011441185
NSN
6505-01-144-1185
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 750.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 750MG I.S. 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: FILM,NONENTERIC; EQUIVALENT TO 10 MEQ POTASSIUM CHLORIDE
Related Searches:
NDC00074-7804-13
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011441185
NSN
6505-01-144-1185
NDC00074-7804-13
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011441185
NSN
6505-01-144-1185
MFG
ABBOTT LABORATORIES INC ROSS PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 750.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 750MG I.S. 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: FILM,NONENTERIC; EQUIVALENT TO 10 MEQ POTASSIUM CHLORIDE
Related Searches:
NDC00087-0770-43
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011441185
NSN
6505-01-144-1185
NDC00087-0770-43
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011441185
NSN
6505-01-144-1185
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 750.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 750MG I.S. 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: FILM,NONENTERIC; EQUIVALENT TO 10 MEQ POTASSIUM CHLORIDE
Related Searches:
NDC00245-0041-01
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011441185
NSN
6505-01-144-1185
NDC00245-0041-01
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011441185
NSN
6505-01-144-1185
MFG
UPSHER-SMITH LABORATORIES INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 750.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 750MG I.S. 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: FILM,NONENTERIC; EQUIVALENT TO 10 MEQ POTASSIUM CHLORIDE
Related Searches:
NDC00245-0041-11
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011441185
NSN
6505-01-144-1185
NDC00245-0041-11
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011441185
NSN
6505-01-144-1185
MFG
UPSHER-SMITH LABORATORIES INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 750.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 750MG I.S. 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: FILM,NONENTERIC; EQUIVALENT TO 10 MEQ POTASSIUM CHLORIDE
Related Searches:
NDC00281-3131-17
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011441185
NSN
6505-01-144-1185
NDC00281-3131-17
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011441185
NSN
6505-01-144-1185
MFG
SAVAGE LABORATORIES DIV OF ALTANA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 750.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 750MG I.S. 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: FILM,NONENTERIC; EQUIVALENT TO 10 MEQ POTASSIUM CHLORIDE
Related Searches:
NDC00281-3131-18
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011441185
NSN
6505-01-144-1185
NDC00281-3131-18
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011441185
NSN
6505-01-144-1185
MFG
SAVAGE LABORATORIES DIV OF ALTANA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 750.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 750MG I.S. 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: FILM,NONENTERIC; EQUIVALENT TO 10 MEQ POTASSIUM CHLORIDE